
Nordic Bioscience A/S, a Danish company and world leader in biomarker development, announced the signing of an investment from KKR, a leading global investment firm. KKR is making the investment through the firm’s Health Care Strategic Growth Fund, which is focused on investing in leading high-growth health care companies for which KKR can be a […]